Kepos Capital LP Zoetis Inc. Transaction History

Kepos Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$112.57 - $128.43 $717,858 - $818,998	-6,377 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$97.98 - $114.28 $624,818 - $728,763	6,377 New	6,377 $724,000
Q1 2019 May 13, 2019	SELL	$81.56 - $100.67 $5.04 Million - $6.22 Million	-61,821 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$79.28 - $95.27 $3.32 Million - $3.99 Million	41,829 Added 209.23%	61,821 $5.29 Million
Q3 2018 Nov 13, 2018	SELL	$83.5 - $93.23 $4.84 Million - $5.41 Million	-57,983 Reduced 74.36%	19,992 $1.83 Million
Q2 2018 Aug 13, 2018	BUY	$79.9 - $89.2 $1.3 Million - $1.45 Million	16,247 Added 26.32%	77,975 $6.64 Million
Q1 2018 May 14, 2018	BUY	$71.51 - $84.69 $4.41 Million - $5.23 Million	61,728 New	61,728 $5.16 Million
Q4 2017 Feb 12, 2018	SELL	$63.24 - $72.8 $513,761 - $591,427	-8,124 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$59.73 - $65.4 $485,246 - $531,309	8,124	8,124 $518,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.